Fat jabs blow £1bn gap in grocery store gross sales as demand for alcohol and crisps falls

Fat jabs have shaved over £1billion off Britain’s grocery bills as millions of users ditch junk food.

The number of households on weight-loss medications has hit 2.6 million, according to the latest figures from market researchers Worldpanel by Numerator.

It means that as many users are now found in British households as vegans and pescatarians combined.

Analysis shows around one in 12 homes (8.5 per cent) have at least one person taking the appetite-suppressing drugs, three-and-a-half times more than two years ago.

Known as GLP-1s and sold under brand names including Mounjaro and Wegovy, their meteoric rise is having huge implications for food and drink businesses.

The growth of weight loss drugs has hit grocery spend by over £1billion a year, up from £780 million in June – the equivalent of £389 a year from each patient’s basket.

Experts at Worldpanel by Numerator have said that weight-loss medications and their use represent ‘a seismic change’. 

Taken as a weekly injection, the jabs trick the body into thinking it is full, meaning fewer cravings.

The latest figures show 8.5 per cent of households using the medications in August compared with 2.3 per cent in 2024. The proportion has also risen from 6.3 per cent this February.

And now weight loss pills make up 11.2 per cent of GLP-1 users, despite being approved just this summer in the UK, according to the study of 9,629 households.

Chantel Kennaugh, head of public sector and nutrition at Worldpanel by Numberator, said: ‘Our estimates suggest that GLP-1 usage is set to surpass 10 per cent of GB households in 2027.

‘This is not a flash-in-the pan trend, but a seismic change that requires retailers and manufacturers to re-think their strategies.’

The number of men using the drugs has nearly doubled, now making up 32 per cent of users compared to 23 per cent in February.

Spending on alcohol among the cohort of weight-loss drug users has dropped 15 per cent more compared to households who do not have anyone taking the medication.

Medication such as Mounjaro can make drinking less appealing as it changes how the brain responds to pleasure as well as causing side-effects including feeling sick.

Spending on crisps has also dropped 15 per cent.

Nishita Pattni, senior consultant at Worldpanel by Numerator, said: ‘You might see people swapping out three beers for one cocktail.’

But Pattni said some aisles of supermarkets are cashing in as people become more health conscious and want to battle some of the drugs’ unwelcome side effects.

These households spent £78 million more than expected on health and beauty products in the first year after adoption, and 30 per cent said they had spent more on clothing and footwear as their bodies changed. Mouthwash is one category that has benefited as users battle issues like dry mouth.

Some categories are even benefiting from users wanting to treat themselves with affordable indulgences because users of the medication – which can cost up to £350 a month – have less disposable income, Pattni said.

This may explain why spending on hot chocolate has gone up, in addition to the drug making users sensitive to stimulants such as coffee. ‘Bitesize’ versions of chocolates have also risen among this group.

It comes after Tesco chief executive Ken Murphy has said Brits are set to drink less booze this Christmas amid an increased interest in healthy lifestyles. He said he believes there could be a ‘more moderate Christmas’ when it comes to drinking. 

DIY INVESTING PLATFORMS

Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.

Compare the best investing account for you